vialroom

#cagrilintide 2025-05-20

Tuesday30 messages8 participantstimes are UTC
Highlights from this day
  • VialBot — Assay note: JEEP lot B-0329 reported at 96.8% of label content. 20:18
  • c18_column — $94 for a 40 vial and it lasts me longer than the GLP-1 does at my doses, for what its worth 20:19
  • c18_column — how slow are people titrating this compared to cagrilintide 21:36
  • VialBot — Assay note: KP lot KP-0925 reported at 99.2% of label content. 21:58

ok so monotherapy question, did appetite move for you without a GLP-1 alongside

thats the phase 3 one

NP

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

RT

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

titrating dead slow

[edited]
VV

the nausea felt different rather than less, more fullness and less of the queasy wave

VB

Assay note: JEEP lot B-0329 reported at 96.8% of label content.

C1

$94 for a 40 vial and it lasts me longer than the GLP-1 does at my doses, for what its worth

🤝1👍15💀1

genuine question anyone stopped the GLP-1 and kept only this

AA

you cannot tell which of the two is doing what in a combination and i stopped pretending i could, i think

is the nausea profile genuinely different or am i imagining it
the combination is the thing with trial data behind it, monotherapy in here is mostly us guessing

*Janoshik not the other one

is the weekly schedule the same here

is 2.4 the number for this too or am i confusing compounds

[edited]
C1

noticed something around week 14 on monotherapy, well after i had given up expecting to

C1

the reason nausea reads differently is timing, mine arrived on the second day rather than the first

changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing

C1

how slow are people titrating this compared to cagrilintide

🧪2🤝8👍2
CC

ok so i was sceptical about monotherapy and after 5 months im still sceptical, just less so, thats one data point

VB

Assay note: KP lot KP-0925 reported at 99.2% of label content.